Page 1 of Clinical Trials for Drug ZD6474, 93 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Phase II Study of ZD6474 in Advanced NSCLC
Last Updated: August 31, 2009
Condition(s): Lung Cancer
2
Recruiting
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
Last Updated: April 5, 2012
Condition(s): Glioblastoma Multiforme; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Mixed Oligoastrocytoma
3
Active, not recruiting
Study of GemOx and Vandetanib in Advanced Solid Malignancy
Last Updated: April 28, 2011
Condition(s): Advanced Incurable Solid Malignancy
4
Recruiting
A Phase I Trial of Vandetanib (ZD6474) and Selumetinib (AZD6244)for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)
Last Updated: April 26, 2012
Condition(s): Cancer; Non Small Cell Lung Cancer
5
Active, not recruiting
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
Last Updated: April 27, 2011
Condition(s): Non-small Cell Lung Cancer; Lung Cancer
6
Active, not recruiting
Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
Last Updated: February 16, 2012
Condition(s): Glioblastoma Multiforme; Gliosarcoma
7
Active, not recruiting
Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Last Updated: February 17, 2012
Condition(s): Gliosarcoma; Glioblastoma
8
Active, not recruiting
Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib
Last Updated: February 14, 2012
Condition(s): Solid Tumors
9
Active, not recruiting
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade(Registered Trademark)), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroi...
Last Updated: March 14, 2012
Condition(s): Breast Cancer; Colon Cancer; Prostate Cancer; Lung Cancer; Adrenal Cancer; Renal Cancer; Gastric Cancer; Ovarian Cancer; Cervical Cancer; Thyroid Cancer; Sarcoma
10
Active, not recruiting
ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer
Last Updated: February 26, 2011
Condition(s): Carcinoma Breast Stage IV
11
Terminated
Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
Last Updated: March 3, 2011
Condition(s): Breast Cancer
12
Completed
Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent MG
Last Updated: October 10, 2011
Condition(s): Glioblastoma; Gliosarcoma
13
Active, not recruiting
ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer
Last Updated: June 22, 2011
Condition(s): Colorectal Cancer
14
Terminated
An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma
Last Updated: October 23, 2009
Condition(s): Mesothelioma
15
Recruiting
Vandetanib With Everolimus
Last Updated: May 14, 2012
Condition(s): Advanced Cancers
16
Active, not recruiting
Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck
Last Updated: October 30, 2009
Condition(s): Squamous Cell Carcinoma of Head and Neck
17
Recruiting
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
Last Updated: April 30, 2012
Condition(s): Glioblastoma
18
Not yet recruiting
Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
Last Updated: August 9, 2011
Condition(s): Lip and Oral Cavity Squamous Cell Carcinoma; Oral Cavity Verrucous Carcinoma; Precancerous Condition
19
Active, not recruiting
Randomized Study of Docetaxel +/- ZD6474 in Metastatic TCC
Last Updated: February 29, 2012
Condition(s): Transitional Cell Carcinoma; Urothelial Cancer
20
Recruiting
Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer
Last Updated: March 15, 2012
Condition(s): Small Cell Lung Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+ZD6474

Page 1 of Clinical Trials for Drug ZD6474, 93 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About